🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Open label radiolabelled metabolism study of intravenous and oral solution ...
Status
Withdrawn
Location
Quotient Clinical
Start Date
2019-05
Trial ID
NCT02912026
Treatments Being Tested
Single-centre, open-label, non-randomised, single dose study in 2 cohorts o...
Status
Completed
Location
PRA Health Sciences
Start Date
2019-07-30
Trial ID
NCT04039880
Treatments Being Tested
A single oral dose study to investigate the PK and safety of olorofim in mi...
Status
Completed
Location
Orange County Research Centre
Start Date
2021-07-02
Trial ID
NCT04752540
Treatments Being Tested
A Phase I, open label study evaluating safety, tolerability and pharmacokin...
Status
Completed
Location
Covance Clinical Research Unit
Start Date
2017-12-12
Trial ID
NCT03340597
Treatments Being Tested
Non-randomized, multi-centre, open label, uncontrolled, multiple dose, phas...
Status
Withdrawn
Location
Multiple Locations
Start Date
2017-03
Trial ID
NCT03036046
Treatments Being Tested
Open label evaluation of potential interaction of F901318 with cytochrome P...
Status
Completed
Location
Hammersmith Medicines Research
Start Date
2016-01
Trial ID
NCT02680808
Treatments Being Tested
A study to evaluate olorofim (F901318) for the treatment of invasive fungal...
Status
Completed
Location
Valley Fever Institute at Kern Medical Center
Start Date
2018-06-06
Trial ID
NCT03583164
Treatments Being Tested
Double blind, placebo controlled, ascending single oral dose, sequential gr...
Status
Completed
Location
Simbec Orion
Start Date
2015-10
Trial ID
NCT02394483
The purpose of this study is to test measurement tools (questionnaire about...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-12
Trial ID
NCT07712484
This will be an open label study in two parts. In the first part, F901318 (...
Status
Completed
Location
CELERION
Start Date
2016-02
Trial ID
NCT02730442
Treatments Being Tested